?
Johnson Rady A
Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK
1594762
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
1,230,730,000
Price per Share :
$26.49
Equivalence :
$32,602,037,700.00
Transaction History
-
M1,230,730,000 Shares After TransactionValue : $33,648,158,200.00$8,047,802,400.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
-
F1,209,410,000 Shares After TransactionValue : $33,573,221,600.00$591,843,200.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
-
F971,530,000 Shares After TransactionValue : $26,590,776,100.00$6,510,775,600.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.